liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Optimization of P1-P3 groups in symmetric and asymmetric HIV-1 protease inhibitors
Inst. of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.
Inst. of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.
Löwgren, S., Inst. of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.
Dept. of Organ. Pharmaceutical Chem., Uppsala University, Uppsala, Sweden.
Show others and affiliations
2003 (English)In: European Journal of Biochemistry, ISSN 0014-2956, Vol. 270, no 8, 1746-1758 p.Article in journal (Refereed) Published
Abstract [en]

HIV-1 protease is an important target for treatment of AIDS, and efficient drugs have been developed. However, the resistance and negative side effects of the current drugs has necessitated the development of new compounds with different binding patterns. In this study, nine C-terminally duplicated HIV-1 protease inhibitors were cocrystallised with the enzyme, the crystal structures analysed at 1.8-2.3 Å resolution, and the inhibitory activity of the compounds characterized in order to evaluate the effects of the individual modifications. These compounds comprise two central hydroxy groups that mimic the geminal hydroxy groups of a cleavage-reaction intermediate. One of the hydroxy groups is located between the d-oxygen atoms of the two catalytic aspartic acid residues, and the other in the gauche position relative to the first. The asymmetric binding of the two central inhibitory hydroxyls induced a small deviation from exact C2 symmetry in the whole enzyme-inhibitor complex. The study shows that the protease molecule could accommodate its structure to different sizes of the P2/P2' groups. The structural alterations were, however, relatively conservative and limited. The binding capacity of the S3/S3' sites was exploited by elongation of the compounds with groups in the P3/P3' positions or by extension of the P1/P1' groups. Furthermore, water molecules were shown to be important binding links between the protease and the inhibitors. This study produced a number of inhibitors with Ki values in the 100 picomolar range.

Place, publisher, year, edition, pages
2003. Vol. 270, no 8, 1746-1758 p.
Keyword [en]
AIDS, Drug, HIV, Protease, X-ray
National Category
Engineering and Technology
URN: urn:nbn:se:liu:diva-46676DOI: 10.1046/j.1432-1033.2003.03533.xOAI: diva2:267572
Available from: 2009-10-11 Created: 2009-10-11 Last updated: 2011-01-13

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Kvarnström, Ingemar
By organisation
The Institute of TechnologyOrganic Chemistry
In the same journal
European Journal of Biochemistry
Engineering and Technology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 44 hits
ReferencesLink to record
Permanent link

Direct link